Jane Street Group, LLC Lannett CO Inc Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$2.91 - $4.83 $121,603 - $201,836	-41,788 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.17 - $5.74 $117,906 - $162,298	28,275 Added 209.24%	41,788 $195,000
Q1 2021 May 18, 2021	BUY	$5.28 - $9.64 $71,348 - $130,265	13,513 New	13,513 $71,000
Q3 2020 Nov 17, 2020	SELL	$4.9 - $7.12 $70,128 - $101,901	-14,312 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$6.43 - $9.86 $92,026 - $141,116	14,312 New	14,312 $104,000
Q1 2020 May 15, 2020	SELL	$6.36 - $10.05 $91,653 - $144,830	-14,411 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.49 - $12.81 $59,795 - $90,220	-7,043 Reduced 32.83%	14,411 $127,000
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $119,713 - $310,439	21,454 New	21,454 $240,000
Q2 2019 Aug 15, 2019	SELL	$5.22 - $9.08 $90,081 - $156,693	-17,257 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$5.35 - $9.82 $363,093 - $666,463	-67,868 Reduced 79.73%	17,257 $136,000
Q4 2018 Feb 15, 2019	SELL	$3.43 - $6.19 $96,088 - $173,406	-28,014 Reduced 24.76%	85,125 $422,000
Q3 2018 Nov 14, 2018	BUY	$4.75 - $14.5 $537,410 - $1.64 Million	113,139 New	113,139 $537,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.